CN102046155A - 包含多颗粒的具有双重释放特性的固体口服剂型 - Google Patents

包含多颗粒的具有双重释放特性的固体口服剂型 Download PDF

Info

Publication number
CN102046155A
CN102046155A CN2009801202525A CN200980120252A CN102046155A CN 102046155 A CN102046155 A CN 102046155A CN 2009801202525 A CN2009801202525 A CN 2009801202525A CN 200980120252 A CN200980120252 A CN 200980120252A CN 102046155 A CN102046155 A CN 102046155A
Authority
CN
China
Prior art keywords
weight
solid dosage
polymer
copolymer
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801202525A
Other languages
English (en)
Chinese (zh)
Inventor
F·甘贝尔托
A-S·达维奥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flamel Technologies SA
Original Assignee
Flamel Technologies SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flamel Technologies SA filed Critical Flamel Technologies SA
Publication of CN102046155A publication Critical patent/CN102046155A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
CN2009801202525A 2008-04-18 2009-04-17 包含多颗粒的具有双重释放特性的固体口服剂型 Pending CN102046155A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7125008P 2008-04-18 2008-04-18
US61/071,250 2008-04-18
FR0852627A FR2930147B1 (fr) 2008-04-18 2008-04-18 Forme orale solide dotee d'un double profil de liberation
FR0852627 2008-04-18
PCT/FR2009/050719 WO2009138642A1 (fr) 2008-04-18 2009-04-17 Forme orale solide dotee d'un double profil de liberation comprenant des multiparticules

Publications (1)

Publication Number Publication Date
CN102046155A true CN102046155A (zh) 2011-05-04

Family

ID=40110982

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801202525A Pending CN102046155A (zh) 2008-04-18 2009-04-17 包含多颗粒的具有双重释放特性的固体口服剂型

Country Status (14)

Country Link
US (1) US20090291137A1 (enExample)
EP (1) EP2276474B1 (enExample)
JP (1) JP5687185B2 (enExample)
KR (1) KR101380507B1 (enExample)
CN (1) CN102046155A (enExample)
AU (1) AU2009247921B2 (enExample)
BR (1) BRPI0910572B1 (enExample)
CA (1) CA2721232C (enExample)
ES (1) ES2721849T3 (enExample)
FR (1) FR2930147B1 (enExample)
IL (1) IL208572A (enExample)
MX (1) MX339671B (enExample)
WO (1) WO2009138642A1 (enExample)
ZA (1) ZA201007238B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
EP2704689B1 (en) 2012-04-19 2018-11-28 Glatt AG Taste-masked pharmaceutical compositions containing diclofenac
BR112017005525A2 (pt) * 2014-09-30 2017-12-05 Dow Global Technologies Llc dispersões de etilcelulose aquosas com aditivo polimérico
BR112017014953A2 (pt) * 2015-01-12 2018-03-13 Nano Pharmaceutical Laboratories Llc microglóbulos de liberação controlada em camadas e métodos para produção dos mesmos
WO2017061431A1 (ja) * 2015-10-05 2017-04-13 富山化学工業株式会社 ソリスロマイシンを含む錠剤
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
FR3089405A1 (fr) 2018-12-07 2020-06-12 Urgo Recherche Innovation Et Developpement Dispositif de retenue et système de contention comprenant un article de contention et un tel dispositif de retenue
FR3089406B1 (fr) 2018-12-07 2020-11-20 Urgo Rech Innovation Et Developpement Dispositif de retenue et système de contention comprenant un article de contention et un tel dispositif de retenue
CN113993523A (zh) 2019-04-17 2022-01-28 指南针探路者有限公司 用赛洛西宾治疗抑郁症和其他各种病症
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
CA2141582C (en) * 1992-08-05 2003-09-30 Angelo Mario Morella Pelletised pharmaceutical composition
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
US5458888A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
JPH0826977A (ja) * 1994-07-19 1996-01-30 Tanabe Seiyaku Co Ltd 溶出制御型経口製剤
TW580397B (en) * 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
US8545880B2 (en) * 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
EP1258241A1 (en) * 2001-05-16 2002-11-20 BIOPROGRESS S.p.A. Method of increasing the bioavailability of nimesulide
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US7939102B2 (en) * 2002-06-07 2011-05-10 Torrent Pharmaceuticals Ltd. Controlled release formulation of lamotrigine
US7294347B2 (en) * 2004-06-21 2007-11-13 Council Of Scientific And Industrial Research Coating compositions for bitterness inhibition
US20060263429A1 (en) * 2005-05-20 2006-11-23 Hengsheng Feng Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
KR20070021806A (ko) * 2005-08-19 2007-02-23 (주)아모레퍼시픽 α1-수용체 차단제의 서방형 펠렛제제 및 이의 제조 방법
GB0517205D0 (en) * 2005-08-22 2005-09-28 Novartis Ag Organic compounds
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
RU2434630C2 (ru) * 2006-08-31 2011-11-27 Юранд, Инк. Системы доставки лекарственных средств, включающие в себя твердые растворы слабоосновных лекарственных средств

Also Published As

Publication number Publication date
IL208572A0 (en) 2010-12-30
CA2721232A1 (fr) 2009-11-19
WO2009138642A1 (fr) 2009-11-19
EP2276474B1 (fr) 2019-03-06
ES2721849T3 (es) 2019-08-05
CA2721232C (fr) 2016-03-29
MX339671B (es) 2016-06-03
FR2930147B1 (fr) 2013-02-08
US20090291137A1 (en) 2009-11-26
JP5687185B2 (ja) 2015-03-18
EP2276474A1 (fr) 2011-01-26
ZA201007238B (en) 2011-06-29
AU2009247921A1 (en) 2009-11-19
JP2011518139A (ja) 2011-06-23
MX2010011409A (es) 2010-12-02
BRPI0910572B1 (pt) 2021-10-13
AU2009247921B2 (en) 2013-09-05
IL208572A (en) 2016-02-29
FR2930147A1 (fr) 2009-10-23
BRPI0910572A2 (enExample) 2017-08-08
KR101380507B1 (ko) 2014-04-11
KR20110005876A (ko) 2011-01-19

Similar Documents

Publication Publication Date Title
KR101380507B1 (ko) 다중 미립자를 함유하고 이중 방출 프로파일을 갖는 고체 경구용 제형
AU2006297477B2 (en) Pharmaceutical dosage forms having immediate release and/or controlled release properties
CN101410094B (zh) 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统
JP2008303223A (ja) 脈動用量薬剤経口送達システム
WO2006119153A2 (en) Timed, pulsatile release systems
JP5052602B2 (ja) 制御用量薬物送達システム
WO2009129282A1 (en) Compositions comprising weakly basic drugs and controlled-release dosage forms
US20050226927A1 (en) Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist
US20050220873A1 (en) Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist
US20090136550A1 (en) Modified release formulations of diltiazem
JP2007531727A (ja) Ｇａｂａｂ受容体アゴニストを含有する即時放出特性および／または制御放出特性を有する薬学的剤形
US20050220874A1 (en) Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist
US20050220863A1 (en) Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist
US20050220864A1 (en) Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist
WO2025215658A1 (en) Pharmaceutical compositions of ketotifen
AU2013273835B2 (en) Timed, pulsatile release systems
MX2008004282A (en) Pharmaceutical dosage forms having immediate release and/orcontrolled release properties

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20110504